Import and Export Compliance Tips for FDA-Regulated Industries

Webinar Description

You have probably heard most of the following views from those in your industry regarding import and export compliance responsibilities:

• "I’ve got more important things to do than get involved in the drudgery of imports and exports."
• "Imports and exports are the responsibility of the shipping and receiving department – why do I need to get involved?"
• "I pay my customs broker and freight forwarder to take care of our company’s imports and exports. What am I paying them for then?"

These statements may seem to make perfect sense, but they do not reflect the significant consequences of failing to comply with the import and export laws in today’s post-9/11 environment. This is particularly true for companies that import and export food, cosmetics, medical devices, and pharmaceuticals.

This Arent Fox webinar is designed for the busy import/export manager or in-house counsel to provide some suggestions on how to minimize the risks associated with his or her company’s import and export programs. This event will also cover import and export best practices, some of which involve little or no cost to the company.

You’ll learn more about:

• How import and export rules expose your company to significant risk if left unattended.
• The common import and export mistakes that put your company on the government’s radar screen.
• How to challenge import and export penalty assessments for both major and minor infractions.
• How to implement import and export best practices without breaking your company’s budget.
• Tips and resources available for import and export compliance.

Who should attend?

• Import and export managers
• In-house legal counsel
• Biotechnology, pharmaceutical, medical device and other life sciences organizations.

About the Speakers:

The speaker for this session is Arent Fox Counsel David Hamill. Dave focuses on issues in the areas of international trade, customs, trade policy and disputes, and export controls and sanctions. Dave has represented Fortune 500 companies, including medical and pharmaceutical companies, whose imports and exports are regulated by the Department of Homeland Security (DHS), the Food and Drug Administration (FDA) and the Bureau of Customs and Border Protection (CBP). His experience includes assisting companies with customs audits, including focused assessments, importer self-assessments and NAFTA verifications. Dave has spoken at various industry and client conferences on customs and trade matters.

This webinar will be hosted by Arent Fox Counsel John Dwyer. John has 20 years of experience in starting, financing and growing early stage, venture-backed health care companies. His practice focuses on advising clients on the many regulatory and transactional legal issues faced by drug, device, and healthcare services companies during accelerating growth. John currently serves on the boards of a number of private and not-for-profit organizations, including ALIGN Pharmaceuticals, Inc., CodeRyte, Inc., and the Trust for America’s Health.